First Time Loading...

Biogen Inc
NASDAQ:BIIB

Watchlist Manager
Biogen Inc Logo
Biogen Inc
NASDAQ:BIIB
Watchlist
Price: 219.71 USD 1.01%
Updated: May 6, 2024
Section:
 

Relative Value

The Relative Value of one BIIB stock under the Base Case scenario is 224.58 USD. Compared to the current market price of 219.71 USD, Biogen Inc is Undervalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIIB Relative Value
Base Case
224.58 USD
Undervaluation 2%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.3
P/S
P/S
Price to Sales
3.3
vs History
49
vs Industry
73
Median 3Y
3.6
Median 5Y
3.3
Industry
8.3
Forward
3.3
More Details
27.3
P/E
P/E
Price to Earnings
27.3
vs History
4
vs Industry
6
Median 3Y
20.4
Median 5Y
14
Industry
26.8
Forward
13.9
More Details
19.3
P/OCF
P/OCF
Price to OCF
19.3
vs History
23
vs Industry
9
Median 3Y
18.1
Median 5Y
11.4
Industry
23.3
More Details
29.8
P/FCFE
P/FCFE
Price to FCFE
29.8
vs History
15
vs Industry
5
Median 3Y
20.7
Median 5Y
10.7
Industry
21.4
More Details
2.1
P/B
P/B
Price to Book Value
2.1
vs History
95
vs Industry
45
Median 3Y
2.9
Median 5Y
3.2
Industry
2.6
More Details
3.8
EV/S
EV/S
Enterprise Value to Sales
3.8
vs History
39
vs Industry
60
Median 3Y
3.9
Median 5Y
3.6
Industry
7.5
Forward
3.8
More Details
5.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.1
vs History
30
vs Industry
57
Median 3Y
5.1
Median 5Y
4.2
Industry
9.2
More Details
14
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14
vs History
11
vs Industry
8
Median 3Y
11.7
Median 5Y
9.6
Industry
4.5
Forward
11
More Details
17.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
17.5
vs History
7
vs Industry
7
Median 3Y
13.8
Median 5Y
11.2
Industry
4.4
Forward
13.1
More Details
22.4
EV/OCF
EV/OCF
Enterprise Value to OCF
22.4
vs History
23
vs Industry
7
Median 3Y
19.4
Median 5Y
12.5
Industry
5.6
More Details
28.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
28.7
vs History
23
vs Industry
5
Median 3Y
22.2
Median 5Y
13.8
Industry
3.4
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
95
vs Industry
56
Median 3Y
2
Median 5Y
2.1
Industry
5
More Details

Multiples Across Competitors

BIIB Competitors Multiples
Biogen Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Biogen Inc
NASDAQ:BIIB
31.9B USD 3.3 27.3 14 17.5
US
Abbvie Inc
NYSE:ABBV
284.5B USD 5.2 59 12.8 19.6
US
Amgen Inc
NASDAQ:AMGN
160B USD 5.7 23.8 17.3 26
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
104.2B USD 7.9 26.4 17.7 19.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.7B USD 10.5 28.7 22.9 24
AU
CSL Ltd
ASX:CSL
133.1B AUD 6.2 35.6 21.6 26.7
US
Gilead Sciences Inc
NASDAQ:GILD
80.7B USD 2.9 166.5 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
45.9B USD 6.7 -9.7 -10.5 -8.9
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
KR
Celltrion Inc
KRX:068270
39.2T KRW 18 73.1 44.7 61.6
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD 7.3 60.8 27.9 47

See Also

Summary
BIIB intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIIB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIIB stock valuation using valuation multiples.
Wall Street Estimates
BIIB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIIB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.